(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CUVUE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CUVUE

ST13

US500000079359922

Class

5, 44

Filing

79359922

Registration

7318381

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

22

Latest update

06/06/2024

Trademark type

Word

Nice classes

5, 44

Filing date

11/09/2022

Registration date

03/05/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/05/2024

Last transaction

03/05/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

33

Owner location

FR

Examiner

KETCHUM, BRENDAN

Law office

N70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

ORPHALAN

Representatives

Heather Smith-Carra Banner & Witcoff, Ltd.

Technical classification

Nice Classes

Class 5Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of Wilson's disease; pharmaceutical products in the nature of medicines for the treatment of Wilson's disease; chemical preparations for the treatment of Wilson's disease for medical use; chemical preparations for the treatment of Wilson's disease for pharmaceutical use; medicinal substances for the treatment of Wilson's disease; medicinal preparations for the treatment of Wilson's disease; chemical preparations for medical or pharmaceutical use for the treatment of Wilson's disease; pharmaceutical products in the nature of medicines and medicines for the treatment of Wilson's disease; pharmaceutical preparations for the diagnosis of Wilson's disease; pharmaceutical and chemical preparations for measuring copper levels; chemical reagents for medical usefor the diagnosis of Wilson's disease; chemical reagents for diagnostic use in patients suffering from Wilson's disease; pre-filled syringes sold filled with medicine for the treatment of Wilson's disease for medical use; medicated serums for diagnostic use for the diagnosis of Wilson's disease; biological preparations in the nature of medicines for medical use for measuring copper in patients suffering from Wilson's disease; chemical preparations in the nature of medicines for medical use for measuring copper in patients suffering from Wilson's disease; clinical diagnostic reagents; diagnostic preparations in the nature of medicines for medical use for the treatment of Wilson's disease; medical diagnostic reagents and assays for analyzing body fluids to diagnose the level of copper

Class 44

Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services for diagnosing the level of copper in patients suffering from Wilson's disease; medical screening; health care for patients suffering from Wilson's disease; health assessment services for patients suffering from Wilson's disease; home-visit nursing care; blood analysis services provided by medical laboratories for patients suffering from Wilson's disease; medical clinic services and medical analysis services provided by medical laboratories for diagnostic purposes for patients suffering from Wilson's disease; medical analysis services provided by medical laboratories for diagnostic purposes to measure copper levels in patients suffering from Wilson's disease; medical diagnostic testingmonitoring and reporting services for patients suffering from Wilson's disease; medical testing for diagnostic or treatment purposes in the field of Wilson's disease

Publications

History of USPTO decisions and trademark events.

22 publications found

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

06/06/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/05/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

03/05/2024

GPNX

NOTIFICATION PROCESSED BY IB

12/19/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/19/2023

PUBO

PUBLISHED FOR OPPOSITION

12/19/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/29/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

11/29/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/29/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/08/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/18/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/18/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/18/2023

RFNT

REFUSAL PROCESSED BY IB

07/05/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/09/2023

RFRR

REFUSAL PROCESSED BY MPU

06/09/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

04/26/2023

CNRT

NON-FINAL ACTION WRITTEN

04/25/2023

DOCK

ASSIGNED TO EXAMINER

04/13/2023

MAFR

APPLICATION FILING RECEIPT MAILED

01/13/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/09/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/06/2023

Continuous trademark protection

Get notified about every new filing that threatens CUVUE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.